Last Updated: November 8, 2026

Patent Applications for imatinib mesylate

« Back to Dashboard

US Patent Applications for imatinib mesylate

Subscribe to access the full database, or Start Trial
US Patent Application	Patent No.	Title	Patent Filing Date	Patent Application Status	Status Updated
⤷ Start Trial	⤷ Start Trial		0000-00-00		0000-00-00
⤷ Start Trial	⤷ Start Trial		0000-00-00		0000-00-00
⤷ Start Trial	⤷ Start Trial		0000-00-00		0000-00-00
⤷ Start Trial	⤷ Start Trial		0000-00-00		0000-00-00
⤷ Start Trial	⤷ Start Trial		0000-00-00		0000-00-00
⤷ Start Trial	⤷ Start Trial	MANNICH BASE PRODRUGS OF 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES	2001-05-24	Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362	2008-04-21
>US Patent Application	>Patent No.	>Title	>Patent Filing Date	>Patent Application Status	>Status Updated

WIPO Patent Applications for imatinib mesylate

Subscribe to access the full database, or Start Trial
WIPO Patent Application	Title	Patent Filing Date
⤷ Start Trial
⤷ Start Trial
⤷ Start Trial
⤷ Start Trial
⤷ Start Trial
⤷ Start Trial
>WIPO Patent Application	>Title	>Patent Filing Date

Japanese Patent Applications for imatinib mesylate

Subscribe to access the full database, or Start Trial
JP Patent Application	Title	Patent Filing Date
⤷ Start Trial
⤷ Start Trial
⤷ Start Trial
⤷ Start Trial
⤷ Start Trial
⤷ Start Trial
>JP Patent Application	>Title	>Patent Filing Date

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.